Invizyne Technologies Inc. (NASDAQ:IZTC – Get Free Report)’s stock price was down 4.2% during trading on Wednesday . The company traded as low as $12.56 and last traded at $12.56. Approximately 13,992 shares changed hands during mid-day trading, a decline of 63% from the average daily volume of 37,617 shares. The stock had previously closed at $13.11.
Invizyne Technologies Price Performance
The firm’s fifty day moving average is $15.72.
Institutional Inflows and Outflows
Institutional investors have recently modified their holdings of the stock. Citadel Advisors LLC acquired a new stake in shares of Invizyne Technologies during the fourth quarter worth $456,000. Geode Capital Management LLC acquired a new stake in shares of Invizyne Technologies in the fourth quarter worth $277,000. Finally, BNP Paribas Financial Markets purchased a new position in Invizyne Technologies in the fourth quarter valued at about $35,000.
About Invizyne Technologies
Invizyne Technologies Inc is a cell-free enzyme-based biomanufacturing technology company. It redefining biomanufacturing by leveraging cell-free, multi-step, enzyme-based systems to efficiently transform natural or renewable resources into highly sought after biochemicals. Invizyne Technologies Inc is based in Monrovia, CA.
Featured Articles
- Five stocks we like better than Invizyne Technologies
- How to trade penny stocks: A step-by-step guide
- Energy Transfer: Powering Data With Dividends and Diversification
- What is the Hang Seng index?
- Qualcomm Stock Is Coiling for a Breakout
- 3 Stocks to Consider Buying in October
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for Invizyne Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invizyne Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
